Formulae recently proposed to estimate renal glomerular filtration rate improve the prediction of carboplatin clearance

被引:11
|
作者
White-Koning, Melanie [1 ,2 ]
Paludetto, Marie Noelle [1 ,2 ,3 ]
Le Louedec, Felicien [1 ,3 ]
Gladieff, Laurence [4 ]
Chevreau, Christine [4 ]
Chatelut, Etienne [1 ,2 ]
Puisset, Florent [1 ,2 ,3 ]
机构
[1] Centre Recherches Cancerol Toulouse, CRCT, INSERM UMR1037, 2 Ave Hubert Curien, CS53717, F-31037 Toulouse, France
[2] Univ Paul Sabatier Toulouse III, Univ Toulouse, 118 Route Narbonne, F-31062 Toulouse, France
[3] Institut Univ Canc Toulousain, Institut Claudius Regaud,Pharm Dept,IUCT,Oncopole, 1 Ave Irene Joliot-Curie, F-31059 Toulouse, France
[4] Institut Univ Canc Toulousain, Institut Claudius Regaud,Oncology Dept,IUCT, Oncopole, 1 Ave Irene Joliot-Curie, F-31059 Toulouse, France
关键词
Carboplatin; Individual dosing; Creatinine; Cystatin C; CYSTATIN-C; SERUM CREATININE; OBESE-PATIENTS; NORMAL-WEIGHT; PERFORMANCE; POPULATION; OVERWEIGHT; EQUATIONS;
D O I
10.1007/s00280-019-04020-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose While doses of carboplatin are mostly individualized according to the Calvert equation based on estimated Glomerular Filtration Rate (eGFR), there is still uncertainty regarding the best formula to predict GFR. Since Janowitz et al. recently proposed a new equation predicting GFR in cancer patients, we aimed to compare this equation to other carboplatin clearance (carboCL) predicting formulae. Methods The actual carboCL of 491 patients was compared to predicted carboCL according to the Calvert formula using several equations to predict GFR (Janowitz, Cockcroft-Gault, MDRD, CKD-EPI, CKD-EPI with cystatin C (CKD-EPI-cysC)); and according to two others that directly predict carboCL (Chatelut and Thomas). The formulae were compared on Mean Percentage Error (MPE), Mean Absolute Percentage Error (MAPE) and percentage of patients with a prediction error above 20% (P20). Results The MPE, MAPE and P20 were, respectively, within the ranges - 5.2 to + 5.9%; 14.0-21.2% and 23-46%. The MAPE and P20 of Calvert-CKD-EPI-cysC were the lowest. The performance of Calvert-CKD-EPI was better than that of other creatinine-based formulae although not significantly different from the Calvert-Janowitz formula. Among formulae based on creatinine only, Calvert-CKD-EPI and Calvert-Janowitz are the least influenced by patient characteristics. Conclusion Whereas CysC improves carboplatin CL prediction, the Calvert-CKD-EPI equation seems the most suitable creatinine-based formula to predict carboCL homogeneously in all subgroups of patients.
引用
收藏
页码:585 / 592
页数:8
相关论文
共 50 条
  • [31] Performance of serum cystatin C versus serum creatinine as a marker of glomerular filtration rate as measured by inulin renal clearance
    Horio, Masaru
    Imai, Enyu
    Yasuda, Yoshinari
    Watanabe, Tsuyoshi
    Matsuo, Seiichi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2011, 15 (06) : 868 - 876
  • [32] Performance of serum cystatin C versus serum creatinine as a marker of glomerular filtration rate as measured by inulin renal clearance
    Masaru Horio
    Enyu Imai
    Yoshinari Yasuda
    Tsuyoshi Watanabe
    Seiichi Matsuo
    Clinical and Experimental Nephrology, 2011, 15 : 868 - 876
  • [33] Estimating Kidney Function in HIV-Infected Adults in Kenya: Comparison to a Direct Measure of Glomerular Filtration Rate by Iohexol Clearance
    Wyatt, Christina M.
    Schwartz, George J.
    Ong'or, Willis Owino
    Abuya, Joseph
    Abraham, Alison G.
    Mboku, Charles
    M'mene, Loice B.
    Koima, Winnie J.
    Hotta, Mathew
    Maier, Paula
    Klotman, Paul E.
    Wools-Kaloustian, Kara
    PLOS ONE, 2013, 8 (08):
  • [34] Reliability of glomerular filtration rate estimating formulas compared to iohexol plasma clearance in critically ill children
    Dhont, Evelyn
    Windels, Charlotte
    Snauwaert, Evelien
    Van der Heggen, Tatjana
    de Jaeger, Annick
    Dhondt, Laura
    Delanghe, Joris
    Croubels, Siska
    Vande Walle, Johan
    De Paepe, Peter
    De Cock, Pieter A.
    EUROPEAN JOURNAL OF PEDIATRICS, 2022, 181 (11) : 3851 - 3866
  • [35] Estimation of cefepime, piperacillin, and tazobactam clearance with iohexol-based glomerular filtration rate in paediatric patients
    Soeorg, Hiie
    Noortoots, Aveli
    Karu, Maarja
    Saks, Kadri
    Lass, Jana
    Lutsar, Irja
    Korgvee, Lenne-Triin
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (06) : 989 - 1001
  • [36] Glomerular filtration rate estimation for carboplatin dosing in patients with gynaecological cancers
    Samani, A.
    Bennett, R.
    Eremeishvili, K.
    Kalofonou, F.
    Whear, S.
    Montes, A.
    Kristeleit, R.
    Krell, J.
    McNeish, I
    Ghosh, S.
    Tookman, L.
    ESMO OPEN, 2022, 7 (02)
  • [37] Diagnostic value of cystatin C and glomerular filtration rate formulae in Chinese nonelderly and elderly populations
    Pei, Xiaohua
    Bao, Lihua
    Xu, Zhaoqiang
    Yan, Chengjing
    He, Juan
    Zhu, Bei
    Wu, Jianqing
    Zhao, Weihong
    JOURNAL OF NEPHROLOGY, 2013, 26 (03) : 476 - 484
  • [38] Optimizing carboplatin dosing by an improved prediction of carboplatin clearance using a CT-enhanced estimate of renal function
    Molenaar-Kuijsten, Laura
    Pieters, Tobias T.
    Veldhuis, Wouter B.
    Moeskops, Pim
    Rijkhorst, Erik Jan
    Dorlo, Thomas P. C.
    Beijnen, Jos H.
    Steeghs, Neeltje
    Rookmaaker, Maarten B.
    Huitema, Alwin D. R.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (10) : 3016 - 3025
  • [39] Measurement of Glomerular Filtration Rate in Patients Undergoing Renal Surgery for Cancer: Estimated Glomerular Filtration Rate versus Measured Glomerular Filtration Rate in the Era of Precision Medicine
    Trevisani, Francesco
    Simeoni, Mariadelina
    Bettiga, Arianna
    Cinque, Alessandra
    Floris, Matteo
    KIDNEY & BLOOD PRESSURE RESEARCH, 2024, 49 (01): : 336 - 344
  • [40] The efficacy of cystatin C assay in the prediction of glomerular filtration rate. Is it a more reliable marker for renal failure?
    Bicik, Z
    Bahcebasi, T
    Kulaksizoglu, S
    Yavuz, O
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2005, 43 (08) : 855 - 861